0001209191-21-042290.txt : 20210621 0001209191-21-042290.hdr.sgml : 20210621 20210621200047 ACCESSION NUMBER: 0001209191-21-042290 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210617 FILED AS OF DATE: 20210621 DATE AS OF CHANGE: 20210621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ADAMS R MARK CENTRAL INDEX KEY: 0001808905 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38957 FILM NUMBER: 211032638 MAIL ADDRESS: STREET 1: C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION STREET 2: 1551 EASTLAKE AVE E STE 200 CITY: SEATTLE STATE: WA ZIP: 98102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adaptive Biotechnologies Corp CENTRAL INDEX KEY: 0001478320 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 270907024 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1551 EASTLAKE AVENUE EAST SUITE 200 CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: 206-659-0067 MAIL ADDRESS: STREET 1: 1551 EASTLAKE AVENUE EAST SUITE 200 CITY: SEATTLE STATE: WA ZIP: 98102 FORMER COMPANY: FORMER CONFORMED NAME: Adaptive TCR Corp DATE OF NAME CHANGE: 20091209 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-06-17 0 0001478320 Adaptive Biotechnologies Corp ADPT 0001808905 ADAMS R MARK C/O ADAPTIVE BIOTECHNOLOGIES CORP. SUITE 200 SEATTLE WA 98102 0 1 0 0 Chief Operating Officer Common Stock 2021-06-17 4 M 0 14583 28.10 A 72687 D Common Stock 2021-06-17 4 S 0 14583 40.00 D 58104 D Stock Option (Right to Buy) 28.10 2021-06-17 4 M 0 14583 0.00 D 2030-04-06 Common Stock 14583 35417 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2021. The options vest with respect to 1/4 of such shares on April 6, 2021, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested. /s/ R Mark Adams by Eric L. Billings, attorney-in-fact 2021-06-21